Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-05

FDA Approved: CLONAZEPAM — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for clonazepam from Alembic Pharmaceuticals Inc., bringing a generic clonazepam product to market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonazepam (generic) (Clonazepam)

Snippet

SUPPL AP for CLONAZEPAM (CLONAZEPAM)